AU4967597A - Anti-helicobacter pylori drugs - Google Patents

Anti-helicobacter pylori drugs

Info

Publication number
AU4967597A
AU4967597A AU49675/97A AU4967597A AU4967597A AU 4967597 A AU4967597 A AU 4967597A AU 49675/97 A AU49675/97 A AU 49675/97A AU 4967597 A AU4967597 A AU 4967597A AU 4967597 A AU4967597 A AU 4967597A
Authority
AU
Australia
Prior art keywords
helicobacter pylori
pylori drugs
drugs
helicobacter
pylori
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49675/97A
Inventor
Yuji Ishibashi
Kenjiro Momo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Publication of AU4967597A publication Critical patent/AU4967597A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4462Non condensed piperidines, e.g. piperocaine only substituted in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AU49675/97A 1996-11-20 1997-11-19 Anti-helicobacter pylori drugs Abandoned AU4967597A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP8-309546 1996-11-20
JP30954696 1996-11-20
JP30671297A JP4237837B2 (en) 1996-11-20 1997-11-10 Anti-Helicobacter pylori drug
JP9-306712 1997-11-10
PCT/JP1997/004199 WO1998022111A1 (en) 1996-11-20 1997-11-19 Anti-helicobacter pylori drugs

Publications (1)

Publication Number Publication Date
AU4967597A true AU4967597A (en) 1998-06-10

Family

ID=26564838

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49675/97A Abandoned AU4967597A (en) 1996-11-20 1997-11-19 Anti-helicobacter pylori drugs

Country Status (3)

Country Link
JP (1) JP4237837B2 (en)
AU (1) AU4967597A (en)
WO (1) WO1998022111A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5028436B1 (en) * 1968-05-06 1975-09-16
JPS5671069A (en) * 1979-11-15 1981-06-13 Kyorin Pharmaceut Co Ltd Preparation of piperidine derivative

Also Published As

Publication number Publication date
WO1998022111A1 (en) 1998-05-28
JP4237837B2 (en) 2009-03-11
JPH10203984A (en) 1998-08-04

Similar Documents

Publication Publication Date Title
AU5059498A (en) Whipstock
AU4781297A (en) Vaccines
AU3406497A (en) Controlled release tablet
AU5259398A (en) Hopper
AU2453897A (en) Video transcoder
AU4851097A (en) Multiple-size cervical collar
AU1718397A (en) Micromixer
AU1704697A (en) Leptin receptor variants
AU1698897A (en) Leptin receptor variants
AU1409100A (en) Drugs
AU4013097A (en) Terazosin capsules
AU4330097A (en) Pharmaceutical compounds
AU3129097A (en) Explosive formulations
AU5160596A (en) Helicobacter pylori cagi region
AU2440597A (en) Wellhead junction system
AU4169897A (en) Pharmaceutical compounds
AU7711096A (en) Cisplatinum comprising pharmaceutical
AU4604397A (en) (o-acyl-p-n-acylamino-phenyl)-o-phosphoethanolamines
AU6343696A (en) Helicobacter clpb
AU7137896A (en) Helicobacter pylori protein
AU697781B3 (en) Stomach-action molluscicides
AU3069697A (en) Explosive formulations
AU4967597A (en) Anti-helicobacter pylori drugs
AU3129197A (en) Explosive formulations
AU1597197A (en) Thienoquinolines